SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Journal of Psychopharmacology
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
0269881108089582v1
23/1/6    most recent
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Mukhopadhaya, K.
Right arrow Articles by Fineberg, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mukhopadhaya, K.
Right arrow Articles by Fineberg, N.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Obsessive-compulsive disorder in UK clozapine-treated schizophrenia and schizoaffective disorder: a cause for clinical concern

K. Mukhopadhaya

National Obsessive Compulsive Disorders Treatment Service, Department of Psychiatry, Queen Elizabeth Hospital, Hertfordshire, UK, Partnership NHS Foundation Trust, Welwyn Garden City, Hertfordshire, UK

R. Krishnaiah

National Obsessive Compulsive Disorders Treatment Service, Department of Psychiatry, Queen Elizabeth Hospital, Hertfordshire, UK, Partnership NHS Foundation Trust, Welwyn Garden City, Hertfordshire, UK

T. Taye

National Obsessive Compulsive Disorders Treatment Service, Department of Psychiatry, Queen Elizabeth Hospital, Hertfordshire, UK, Partnership NHS Foundation Trust, Welwyn Garden City, Hertfordshire, UK

A. Nigam

National Obsessive Compulsive Disorders Treatment Service, Department of Psychiatry, Queen Elizabeth Hospital, Hertfordshire, UK, Partnership NHS Foundation Trust, Welwyn Garden City, Hertfordshire, UK

AJ Bailey

National Obsessive Compulsive Disorders Treatment Service, Department of Psychiatry, Queen Elizabeth Hospital, Hertfordshire, UK, Partnership NHS Foundation Trust, Welwyn Garden City, Hertfordshire, UK

T. Sivakumaran

University of Hertfordshire, College Lane, Hatfield, UK

NA Fineberg

National Obsessive Compulsive Disorders Treatment Service, Department of Psychiatry, Queen Elizabeth Hospital, Hertfordshire, UK, Partnership NHS Foundation Trust, Welwyn Garden City, Hertfordshire, UK; University of Hertfordshire, College Lane, Hatfield, UK, kim.fox{at}hertspartsft.nhs.uk

The association between schizophrenia and obsessive-compulsive disorder (OCD) is complex. This study systematically examined a UK cohort of clozapine-treated individuals with schizophrenia/schizoaffective disorder. Fourteen of 59 cases (24%) scored positively on item H of the Mini-International Neuropsychiatric Interview (MINI) for OCD. The mean Yale— Brown Obsessive-Compulsive Scale (Y-BOCS) score in MINI-positive cases was 17.6 (SD ± 6.3). Sixty-four percent scored 16 or more on the Y-BOCS, representing clinically meaningful illness severity. Seven (50%) patients with OCD had previously received the diagnosis by their treating clinicians and were already receiving with selective serotonin re-uptake inhibitors (SSRIs) treatment. OCD cases scored significantly worse than their non-OCD counterparts on the Abnormal Involuntary Movement Scale (P = 0.01) and the Simpson Angus Scale (SAS; P = 0.01). There was also a non-significant trend toward higher ratings for OCD cases on the Clinical Global Impression-Schizophrenia scale (P = 0.06). Comparing the OCD cases taking SSRI (n = 7) with those not on SSRI (n = 7), significant differences emerged on the SAS (P = 0.03). Our results suggest that OCD is common among patients receiving clozapine for schizophrenic disorders and that the comorbidity is associated with greater motoric impairment. The role of medication in this condition remains unclear.

Key Words: clozapine • OCD • schizophrenia

This version was published on January 1, 2009

Journal of Psychopharmacology, Vol. 23, No. 1, 6-13 (2009)
DOI: 10.1177/0269881108089582


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Schizophr BullHome page
A. M. Achim, M. Maziade, E. Raymond, D. Olivier, C. Merette, and M.-A. Roy
How Prevalent Are Anxiety Disorders in Schizophrenia? A Meta-Analysis and Critical Review on a Significant Association
Schizophr Bull, December 3, 2009; (2009) sbp148v1.
[Abstract] [Full Text] [PDF]



Advertisement